image credit- shutterstock
LordsMed, the pharma division of Mumbai-based Lord's Mark Industries, has entered into an exclusive partnership with Singapore-based diagnostics kit manufacturer Sensing Self to bring world’s first COVID-19 saliva-based rapid antigen test kit to India.
With a reduced turn-around time, the first-of-its-kind non-invasive rapid antigen test kit will make COVID-19 mass screening scalable, a 99% accuracy rate i.e., gold standard, affordable and accessible to facilitate prevention of pandemic spread whenever there is a spike in the infection rate.
The innovative technology collaboration marks LordsMed foray into the fast-growing rapid antigen diagnostic kit segment. It has plans to venture into the OEM manufacturing space in the diagnostics sector with its advanced manufacturing facility at Vasai near Mumbai which will be operational soon.
As a part of the agreement with Sensing Self, Lord’s Mark Industries will collaborate with various government agencies and authorities to offer the saliva-based rapid antigen kits to support large-scale mass screening for COVID-19 at various passenger transit-points like airports apart from offices and manufacturing units. The company will also tie up with primary health centres (PHCs) in various rural areas to strengthen the COVID-19 mass-screening facility in the hinterland of the country.
